Wikisage, the free encyclopedia of the second generation, is digital heritage
Mepolizumab: Difference between revisions
Jump to navigation
Jump to search
(→Links) |
(fix) |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 6: | Line 6: | ||
[https://karmel.miraheze.org/wiki/Mepolizumab karmel(miraheze):Mepolizumab] | [https://karmel.miraheze.org/wiki/Mepolizumab karmel(miraheze):Mepolizumab] | ||
{{Wikidata|Q3306175}} | |||
{{refs}} | |||
Latest revision as of 16:05, 23 January 2020
Mepolizumab is a humanized monoclonal antibody to interleukin-5 (IL-5) which leads to a decrease in production and maturation of eosinophils and results in a reduction in allergic symptoms of asthma and hypereosinophilic síndromes [1]
Links
| References: |